Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women

Maturitas

Volumn 46, Issue 3, 2003, Pages 219-224

  De Leo, Vincenzo ^a,b   La Marca, Antonio ^a   Orlandi, Roberto ^c   Crippa, Donatella ^c   Setacci, Carlo ^b   Petraglia, Felice ^a  

^a Section of Obstetrics and Gynecology   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Lundbeck Italia   (Italy)

Author keywords

Carotid artery pulsatility index; Cyproterone acetate; Estradiol

Indexed keywords

CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DOPPLER FLOWMETRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; OVARIECTOMY; POSTMENOPAUSE; VASODILATATION;

EID: 0242380238     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00192-0     Document Type: Article

References (37)

1. Wagner J.D., Clarkson T.B., St. Clair R.W., et al. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J. Clin. Invest. 88:1991;1995-2002.
2. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of adding progesterone. Arteriosclerosis. 10:1990;1051-1057.
3. Gisclard V., Miller V.M., Vanhoutte P.M. Effect of 17-beta estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244:1998;19-22.
4. Williams J.K., Adams M.R., Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
5. Herrington D.M., Braden G.A., Williams J.K., et al. Endothelial- dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am. J. Cardiol. 73:1994;951-952.
6. Collins P., Rosano G.M., Sarrel P.M., et al. 17-Beta estradiol attenuates acetylcoline-induced coronary arterial constriction in women but no men with coronary heart disease. Circulation. 92:1995;24-30.
7. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 265:1991;1861-1867.
8. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20:1991;47-63.
9. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
10. Gangar K.F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842.
11. Kallikazaros I., Tsioufis C., Zambaras P., Stefanadis C., Toutouzas P. Conjugated estrogen administration improves common carotid artery elastic properties in normotensive postmenopausal women. Clin. Cardiol. 25:2002;167-172.
12. Sendag F., Terek M.C., Karadadas N., Bilgin O. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study. J. Reprod. Med. 46:2001;962-968.
13. Ozsener S., Sagol S., Oztekin K., Bilgin O. The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. Int. J. Gynaecol. Obstet. 69:2000;281-282.
14. Battaglia C., Regnani G., Artini P.G., Genazzani A.R., Primavera M.R., Salvatori M., Volpe A. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy. Gynecol. Endocrinol. 13:1999;223-229.
15. Penotti M., Sironi L., Castiglioni E., Miglierina L., Barletta L., Gabrielli L., Vignali M. Blood flow in the internal carotid and middle cerebral arteries: effects of continuous oral conjugated equine estrogens administration with monthly progestogen supplementation on postmenopausal women. Menopause. 6:1999;225-229.
16. Cacciatore B., Paakkari I., Toivonen J., Tikkanen M.J., Ylikorkala O. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow. Obstet. Gynecol. 92:1998;563-568.
17. Penotti M., Sironi L., Miglierina L., Farina M., Barletta L., Gabrielli L., Vignali M. The effect of tamoxifen and transdermal 17beta-estradiol on cerebral arterial vessels: a randomized controlled study. Am. J. Obstet. Gynecol. 178:1998;801-805.
18. Resnik R., Brink G.W., Plumer M.H. The effect of progesterone on estrogen-induced uterine blood flow. Am. J. Obstet. Gynecol. 128:1977;251-254.
19. Luckas M.J., Gleeve T., Biljan M.M., Buckett W.M., Aird I.A., Drakeley A., Kingsland C.R. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy. Eur. J. Obstet. Gynecol. Reprod. Biol. 76:1998;221-224.
20. Penotti M., Sironi L., Cannata L., Vigano P., Casini A., Gabrielli L., Vignali M. Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. Fertil. Steril. 76:2001;235-240.
21. Sitruk-Ware R. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Menopause. 9:2002;6-15.
22. Rosano G.M., Fini M. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy. Cardiol. Rev. 10:2002;51-60.
23. Rosano G.M., Fini M. Comparative cardiovascular effects of different progestins in menopause. Int. J. Fertil. Womens Med. 46:2001;248-256.
24. Stefanick M.L. Estrogen, progestogens and cardiovascular risk. J. Reprod. Med. 44:1999;221-226.
25. Clarkson T.B. Progestogens and cardiovascular disease. A critical review. J. Reprod. Med. 44:1999;180-184.
26. Sitruk-Ware R. Progestins and cardiovascular risk markers. Steroids. 65:2000;651-658.
27. Rosano G.M., Sarais C., Zoncu S., Mercuro G. The relative effects of progesterone and progestins in hormone replacement therapy. Hum. Reprod. 15:2000;60-73.
28. Jackson S., Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br. J. Obstet. Gynaecol. 105:1998;408-412.
29. Rosenfeld C.R., Killam A.P., Battaglia F.C., Makowski E.L., Meschia G. Effect of estradiol-17, on the magnitude and distribution of uterine blood flow in nonpregnant, oophorectomized ewes. Pediatr. Res. 7:1973;139-148.
30. Jiang C., Sarrel P.M., Poole-Wilson P.A., Collins P. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am. J. Physiol. 263:1992;271-275.
31. Jiang C.W., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br. J. Pharmacol. 104:1991;1033-1037.
32. Penotti M., Farina M., Castiglioni E., Gaffuri B., Barletta L., Gabrielli L., Vignali M. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am. J. Obstet. Gynecol. 175:1996;606-611.
33. Penotti M., Nencioni T., Gabrielli L., Farina M., Castiglioni E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol. 169:1993;1226-1232.
34. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000. Fertil. Steril. 75:2001;898-915.
35. Ross R.K., Paganini-Hill A., Mack T.M., Henderson B.E. Estrogen use and cardiovascular disease. Mishell D.R. Jr. Menopause, physiology and pharmacology. 1987;209-224 Year Book, Chicago.
36. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1987;1102-1109.
37. Chen F.P., Lee N., Wang C.H., Cherng W.J., Soong Y.K. Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women. Fertil. Steril. 69:1998;267-273.